Company news
Tempus Ai, Inc. (NASDAQ:TEM) news
Tempus Ai, Inc. news releases on 6ix. Latest, Jul 16, 2024: Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile…
Press releases — page 4
Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests
July 15, 2024
Tempus Surpasses 500 Research Publications
July 9, 2024
American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM
July 7, 2024
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test
July 1, 2024
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib
June 25, 2024
Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension
June 24, 2024
Tempus Announces Pricing of Initial Public Offering
June 12, 2024